International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 1 , Pages 36-39 , 1 September 2009

Maximum vs. Mono Androgen Blockade and the Risk of Recurrence in Men With Localized Prostate Cancer Undergoing Brachytherapy

  • Ronald C. Chen, M.D., M.P.H.

      Affiliations

    • Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA
    • Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA
    • Corresponding Author InformationReprint requests to: Dr. Ronald C. Chen, Department of Radiation Oncology, Brigham & Women's Hospital, L-2, 75 Francis Street, Boston, MA 02445. Tel: (617) 278-0330; Fax: (617) 732-7347
  • ,
  • Natalia Sadetsky, M.D., M.P.H.

      Affiliations

    • Department of Urology, Program in Urologic Oncology, Urology Outcomes Research Group, UCSF Comprehensive Cancer Center, University of California, San Francisco, CA
  • ,
  • Ming-Hui Chen, Ph.D.

      Affiliations

    • Department of Statistics, University of Connecticut, Storrs, CT
  • ,
  • Peter R. Carroll, M.D.

      Affiliations

    • Department of Urology, Program in Urologic Oncology, Urology Outcomes Research Group, UCSF Comprehensive Cancer Center, University of California, San Francisco, CA
  • ,
  • Anthony V. D'Amico, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA

Received 22 August 2008 ,Revised 14 October 2008 ,Accepted 21 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Previously presented in abstract form at the Genitourinary Cancers Symposium on February 15, 2008.

 Supported by TAP Pharmaceutical Products, Inc.

 Conflict of interest: none.

PII: S0360-3016(08)03741-3

doi: 10.1016/j.ijrobp.2008.10.059

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 1 , Pages 36-39 , 1 September 2009